| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8713022 | Journal of Allergy and Clinical Immunology | 2018 | 38 Pages |
Abstract
These data demonstrate that autologous T-cell gene therapy corrects SAP-dependent defects and might offer an alternative therapeutic option for patients with X-linked lymphoproliferative disease 1.
Keywords
HSCTSLAM-associated proteinXLPTFHLCLPD-1HVSHLHCTLnatural killerMOIX-linked lymphoproliferative diseaseLymphoblastoid cell lineFollicular helper T cellsSAPphycoerythrincytotoxic T lymphocyteHemophagocytic lymphohistiocytosisHerpesvirus saimiriprogrammed cell death protein 1Hematopoietic stem cell transplantationmultiplicity of infectionT follicular helper
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Neelam MSc, Ben PhD, Begona PhD, Sujal MD, Ida PhD, Adrian J. MBBS, PhD, H. Bobby MBBS, PhD, Claire MBBS, PhD,